Clinical Trials
Braintumor Website

There are 6 trials:
Facility: CHRU de Lille
NCT Trial Name# of Centers

NCT02234050

  Trabectedin for Recurrent Grade II/III Meningioma
47

NCT01345370

  Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients
9

NCT01601184

  Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway
6

NCT01305122

  Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma
5

NCT01857453

  Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas
2

NCT02307604

  SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access
2



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites